[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341914-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341914-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","factors-influencing-outcomes-and-survival-in-anal-cancer-prognostic-factors-analysis","Factors Influencing Outcomes and Survival in Anal Cancer - Prognostic factors analysis","","Study objectives focus on identifying prognostic factors shaping current management of anal cancer. A retrospective review analyzed management and outcomes across a seven-year period (2016–2023), evaluating demographic characteristics, clinical presentation, and patient outcomes at a single institution. Kaplan–Meier methods compared survival between cohorts, while log-rank testing assessed significance. Cox proportional hazards regression estimated hazard ratios with confidence intervals and p-values. The median follow-up was 29.8 months with 75 patients included.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/factors-influencing-outcomes-and-survival-in-anal-cancer-prognostic-factors-analysis/341914/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/factors-influencing-outcomes-and-survival-in-anal-cancer-prognostic-factors-analysis/341914.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s primary aim regarding anal cancer outcomes?","Question",{"text":63,"@type":64},"The study aimed to ascertain prognostic factors influencing the current management of anal cancer and to evaluate how patient and clinical features relate to outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were survival differences analyzed between patient cohorts?",{"text":68,"@type":64},"Kaplan–Meier survival analysis estimated survival differences, with log-rank testing used to determine statistical significance.",{"name":70,"@type":61,"acceptedAnswer":71},"Which findings were identified as adverse prognostic indicators?",{"text":72,"@type":64},"Adverse indicators included T4 disease, poorly differentiated tumors, N2 nodal status, and metastatic disease at diagnosis, each associated with higher hazard ratios and statistically significant p-values.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341914,1790188542,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Article  \nFactors Influencing Outcomes and Survival in Anal Cancer  \nHugo C. Temperley 1,2,3, *, Benjamin M. Mac Curtain 2, Niall J. O’Sullivan 1,2, Cormac Mulhall 2,  \nTatiana S. Temperley 2, Brian J. Mehigan 2, John O. Larkin 2, Paul H. McCormick 2, Colm Kerr 4, David Gallagher 5,6, Colm Bergin 4, Charles Gillham 7 and Michael E. Kelly 2,3  \nCitation: Temperley, H.C.; Mac Curtain, B.M.; O’Sullivan, N.J.; Mulhall, C.; Temperley, T.S.; Mehigan, B.J.; Larkin, J.O.; McCormick, P.H.; Kerr, C.; Gallagher, D.; et al. Factors Influencing Outcomes and Survival in Anal Cancer. Curr. Oncol. 2024, 31, 5151–5163. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)curroncol31090381  \nReceived: 21 July 2024  \nRevised: 27 August 2024  \nAccepted: 30 August 2024  \nPublished: 2 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Radiology, St. James’s Hospital, D08 NHY1 Dublin, Ireland  \n2 Department of Surgery, St. James’s Hospital, D08 NHY1 Dublin, Ireland  \n3 Trinity St. James’s Cancer Institute, D08 NHY1 Dublin, Ireland  \n4 Department of Infectious Diseases, St. James’s Hospital, D08 NHY1 Dublin, Ireland  \n5 Department of Medical Oncology, St. James’s Hospital, D08 NHY1 Dublin, Ireland  \n6 Department of Genetics, St. James’s Hospital, D08 NHY1 Dublin, Ireland  \n7 Department of Radiation Oncology, St. James’s Hospital, D08 NHY1 Dublin, Ireland  \n* Correspondence: [temperlh@tcd.ie](temperlh@tcd.ie)  \nAbstract: Background: We aim to ascertain prognostic factors in the current management of anal cancer within this study. Methods: We reviewed the management and outcomes of anal cancer cases over a seven-year period, inclusive (2016–2023) . The primary objectives were to assess the demographic characteristics, clinical presentation, and outcomes of all anal cancer patients within our institution. Kaplan–Meier survival analysis was used to estimate survival differences between cohorts, with statistical significance determined using log-rank testing. Cox proportional hazards regression was utilised to identify prognostic factors. Cox regression hazard ratios were reported along with confidence intervals and p-values. Results: The median follow-up time for the study was 29.8 months. Seventy-five patients with anal cancer were included in this study, with 88%(66/75) being squamous cell carcinoma (SCC) and the majority having regional disease (82.7%(62/75)) . The median age at diagnosis was 63.4 years (36–94) . There was a female preponderance (57.3%(43/75)) . In total, 84%(63/75) underwent definitive chemoradiation (dCRT), with 7/63 (11.1%) requiring a salvage abdomino-perineal resection (APR) for residual or recurrent disease. Adverse prognostic indicators include those with T4 disease hazard ratio = 3.81,(95% CI 1.13–12.83, * p = 0.04), poorly differentiated tumour disease HR = 3.37,(95% CI 1.13–10.02, * p = 0.04), having N2 nodal status HR = 5.03,(95% CI 1.11–22.8,* p = 0.04), and having metastatic disease at diagnosis HR = 5.8, (95% CI 1.28–26.42,* p = 0.02) . Conclusion: Presenting characteristics including stage, nodal, and differentiation status remain key prognostic indicators in those diagnosed with anal malignancy.  \nKeywords: anal cancer; oncological outcomes; survival; recurrence; treatment response; salvage surgery  \n1. Introduction  \nAnal cancer remains a rare disease, accounting for only about 2% of all gastrointestinal tract (GIT) malignancies [1,2] . Despite this, its diagnosis carries significant clinical, psychological, and public health implications. Anal cancer is largely classified into two subtypes: squamous cell carcinoma (SCC) and adenocarcinoma [1,3] . SCC acc","cbCaigD69HaaT8it","https://ap.wps.com/l/cbCaigD69HaaT8it","pdf",1362314,13,"English","# Abstract\n# Introduction\n## Disease overview and subtypes\n## Diagnostic challenges\n## Treatment evolution and organ preservation\n## Incidence trends and prognostic context","[{\"question\":\"What was the study’s primary aim regarding anal cancer outcomes?\",\"answer\":\"The study aimed to ascertain prognostic factors influencing the current management of anal cancer and to evaluate how patient and clinical features relate to outcomes.\"},{\"question\":\"How were survival differences analyzed between patient cohorts?\",\"answer\":\"Kaplan–Meier survival analysis estimated survival differences, with log-rank testing used to determine statistical significance.\"},{\"question\":\"Which findings were identified as adverse prognostic indicators?\",\"answer\":\"Adverse indicators included T4 disease, poorly differentiated tumors, N2 nodal status, and metastatic disease at diagnosis, each associated with higher hazard ratios and statistically significant p-values.\"}]","Factors Influencing Outcomes and Survival in Anal Cancer - Prognostic factors analysis | PDF",1790044336,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bf3f268cf179774a0274ebe5222515c.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab0a969f04bcc512b69cc8beb2538296.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7422ad255995d6c9a84cc47f9ab29f5.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/384623e6b4820eec8445dcdbd057ee93.webp",980,1385]